eligibility for clinicaltrials:NCT01081327 [clinicaltrials_resource:931c6a3fbe720602a7864c9f149af037]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT01081327 [clinicaltrials_resource:931c6a3fbe720602a7864c9f149af037]
Bio2RDF identifier
931c6a3fbe720602a7864c9f149af037
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:931c6a3fbe720602a7864c9f149af037
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
study population [clinicaltrials_vocabulary:study-population]
All patients receiving Warfarin for lone atrial fibrillation
text [clinicaltrials_vocabulary:text]
Inclusion Criteria:
...... th increased risk of bleeding.
identifier
clinicaltrials_resource:931c6a3fbe720602a7864c9f149af037
title
eligibility for clinicaltrials:NCT01081327
@en
type
label
eligibility for clinicaltrials ...... c6a3fbe720602a7864c9f149af037]
@en